Inhibition of RAC1 activator DOCK2 ameliorates cholestatic liver injury via regulating macrophage polarisation and hepatic stellate cell activation

Abstract Background The Rho GTPase Rac family small GTPase 1 (RAC1) is considered a promising fibrotic therapeutic target, but the role of its activator, dedicator of cytokinesis 2 (DOCK2), in liver fibrosis is largely unknown. This study aimed to investigate the expression and role of DOCK2 in chol...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Jianli Qiu, Yitong Qu, Yinli Li, Cancan Li, Junling Wang, Lu Meng, Xiaojin Jing, Jiangping Fu, Yan Xu, Yuna Chai
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	BMC 2025-02-01
Ráidu:	Biology Direct
Fáttát:	DOCK2 RAC1 Cholestasis Liver fibrosis Hepatic stellate cell Macrophage polarisation
Liŋkkat:	https://doi.org/10.1186/s13062-025-00612-3
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!